Study of 14-3-3 η eta protein in juvenile idiopathic arthritis

Abstract Background Juvenile idiopathic arthritis (JIA) refers to all types of arthritis that begin before the age of 16 and last more than 6 weeks, with no known cause. The 14-3-3 η eta protein is a new biomarker linked to the development of rheumatoid arthritis and joint destruction. We sought to evaluate the 14-3-3 η eta protein’s potential as a diagnostic biomarker for JIA and its correlation with both functional outcome and disease activity. Results Significant levels of 14-3-3 η eta protein were found in rheumatoid factor (RF)-positive polyarticular JIA and RF-negative polyarticular JIA patients. Enthesitis-related arthritis (ERA) is associated with the lowest value of 14-3-3 η eta. 14-3-3 eta protein was significantly positively linked with CHAQ and JADAS 27 ( p = 0.008 & 0.001, respectively). Conclusion The 14-3-3 η eta protein could be used as a biomarker to diagnose and monitor JIA. Significant levels of 14-3-3 η eta protein can be found in RF-positive polyarticular JIA and RF-negative polyarticular JIA patients. The 14-3-3 η eta protein correlates positively with disease activity and functional outcome in JIA.

Authors

Institutions

Publication Details

Journal
Egyptian Rheumatology and Rehabilitation
Published
2025-06-07
DOI
https://doi.org/10.1186/s43166-025-00338-0
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of 14-3-3 η eta protein in juvenile idiopathic arthritis

Yasser Abd-Elaziz Abd-Elhamid, Imtiaz Ahmed, Noha Hosni Ibrahim, Nashwa Ismail Hashaad et al.
Egyptian Rheumatology and Rehabilitation
Autoimmune and Inflammatory Disorders Research
article

Study of 14-3-3 η eta protein in juvenile idiopathic arthritis

Yasser Abd-Elaziz Abd-Elhamid, Imtiaz Ahmed, Noha Hosni Ibrahim, Nashwa Ismail Hashaad, Khaled Omar Elfarouk Zaiton
article en

Abstract

Abstract Background Juvenile idiopathic arthritis (JIA) refers to all types of arthritis that begin before the age of 16 and last more than 6 weeks, with no known cause. The 14-3-3 η eta protein is a new biomarker linked to the development of rheumatoid arthritis and joint destruction. We sought to evaluate the 14-3-3 η eta protein’s potential as a diagnostic biomarker for JIA and its correlation with both functional outcome and disease activity. Results Significant levels of 14-3-3 η eta protein were found in rheumatoid factor (RF)-positive polyarticular JIA and RF-negative polyarticular JIA patients. Enthesitis-related arthritis (ERA) is associated with the lowest value of 14-3-3 η eta. 14-3-3 eta protein was significantly positively linked with CHAQ and JADAS 27 ( p = 0.008 & 0.001, respectively). Conclusion The 14-3-3 η eta protein could be used as a biomarker to diagnose and monitor JIA. Significant levels of 14-3-3 η eta protein can be found in RF-positive polyarticular JIA and RF-negative polyarticular JIA patients. The 14-3-3 η eta protein correlates positively with disease activity and functional outcome in JIA.

Egyptian Rheumatology and RehabilitationVol. 52(1)
Benha University (EG)
Openalex Percentile: Top 83%
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.